Otonomy Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update

Back to Jobs

Company to Host Conference Call and Webcast Today at 4:30 p.m. ET. SAN DIEGO , March 07, 2016 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today

Apply Now